MARKET

GNCA

GNCA

Genocea
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.820
+0.060
+3.41%
Closed 16:00 04/08 EDT
OPEN
1.760
PREV CLOSE
1.760
HIGH
1.830
LOW
1.720
VOLUME
91.65K
TURNOVER
--
52 WEEK HIGH
11.28
52 WEEK LOW
1.100
MARKET CAP
50.31M
P/E (TTM)
-0.8024
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average GNCA stock price target is 16.40 with a high estimate of 32.00 and a low estimate of 7.00.

EPS

GNCA News

More
  • Genocea to Present Virtually at the 19th Annual Needham Healthcare Conference
  • GlobeNewswire · 8h ago
  • Genocea Biosciences (GNCA) Investor Presentation - Slideshow
  • Seeking Alpha - Article · 03/17 21:44
  • How Not To Day Trade
  • Benzinga · 03/06 17:44
  • UPDATE: Hearing Genocea Granted European Patent EP2665490 For 'Vaccines And Compositions Against Streptococcus Pneumoniae'
  • Benzinga · 03/04 15:19

Industry

Biotechnology & Medical Research
+3.06%
Pharmaceuticals & Medical Research
+2.82%

Hot Stocks

Symbol
Price
%Change

About GNCA

Genocea Biosciences, Inc. is a biopharmaceutical company developing personalized cancer immunotherapies. The Company’s Antigen Lead Acquisition System (ATLAS) technology platform allows to identify targets based on each person’s tumor antigen-specific T cell responses. Using ATLAS, the Company can improve neoantigens for inclusion in its immunotherapies and exclude inhibitory antigens that exert an immunosuppressive effect on anti-tumor immune responses. It provides GEN-009 program, which is a neoantigen vaccine candidate. The Company is conducting a Phase 1/2a clinical trial across a range of solid tumor types. It also provides GEN-011, which is a neoantigen-specific adoptive T cell therapy.
More

Webull offers kinds of Genocea Biosciences Inc stock information, including NASDAQ:GNCA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GNCA stock news, and many more online research tools to help you make informed decisions.